Hummsa Biotech

Hummsa Biotech is a biopharmaceutical company based in Ahmedabad, India, dedicated to the development and manufacturing of biosimilars and innovative biologics. The company leverages expertise in recombinant DNA technology and complex peptide synthesis to create affordable versions of high-value therapeutic agents. Its primary focus areas include endocrinology, metabolic disorders, and oncology, with a pipeline featuring biosimilars for Teriparatide, Liraglutide, and Semaglutide. Hummsa Biotech operates a state-of-the-art R&D facility designed to meet international regulatory standards for biotherapeutic production. By focusing on difficult-to-manufacture molecules, the firm aims to address significant unmet medical needs in both domestic and emerging global markets.